Your cart is empty.
Tecan has launched the Freedom EVOlyzer®-2 for fully guided, automated processing of ELISAs through its new generation EVOlution™ 2.0 software, which offers an exceptionally user-friendly graphical user interface with optional touchscreen and a number of new application-oriented features.
Tecan's IVD-D compliant Freedom EVOlyzer has proved to be a highly reliable tool for automated ELISA processing in clinical diagnostics for more than ten years. The open-platform Freedom EVOlyzer-2 automates ELISA kits from a variety of manufacturers and manages the entire workflow, from organizing the initial worktable configuration to providing the final assay results, calculated for each reagent kit's lot constant.
The EVOlution 2.0 software performs many routine clinical diagnostics tasks, such as continuous sample loading and automated processing of pre-dilution factors. A volume pre-checking function ensures there are sufficient reagents for all scheduled tasks, allowing long walkaway times for the user with complete peace of mind. The software's simple graphical loading dialogues and loading interface provide easy operation throughout the process, and its flexible scheduling options allow the order of assay processing to be defined and prioritized. Assays can also be bunched into profiles that facilitate everyday routine tasks and the system is suitable for working in batch mode using worklists or via an ASTM connection.
Tecan (www.tecan.com) is a leading global supplier of laboratory instruments and solutions for the biopharma, forensic and diagnostic industries. The company specializes in the development, production and distribution of automation solutions for life science laboratories. Through its REMP subsidiary (www.remp.com), Tecan is the premier supplier of automated laboratory storage and logistics systems. Tecan's clients include pharmaceutical and biotech companies, university research departments, diagnostic laboratories and companies as well as forensics laboratories. Founded in Switzerland in 1980, the company has production, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2007, Tecan achieved sales of CHF 414.4 million (USD 345.3 million; EUR 252.7 million). Registered shares of the Tecan Group are traded on the SWX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Valor: 1210019).
Tecan Group Ltd.
T +41 44 922 81 11
F +41 44 922 81 12